What's breaking now, across thousands of outlets.
When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for quick access have been stymied.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
The court was hearing Mhatre's challenge to stringent conditions imposed by the Bombay High Court while granting him relief in the Dombivli assault case.
In the wake of its high-profile setback in heart disease late last week, Novartis really needed a win. It didn’t get one. The Swiss pharma said Tuesday that in a late-stage ...
Beam Therapeutics on Tuesday shared additional data from an early-stage trial of its gene therapy candidate in a rare disease that causes lung and liver damage.
Good rehabilitation starts with a simple question: “What do you want to get back to?” The answer may be different for every person. And that answer becomes an important part of the treatment
Four Costa Blanca communities are coming together this September for a charity walk supporting people living with Alzheimer’s and the […]
